Altered locus coeruleus links to atrophy and hypometabolism in individuals with high Alzheimer’s disease biomarkers.

The locus coeruleus (LC), the first region to contain tau pathology in Alzheimer’s disease (AD), releases norepinephrine, which has a neuroprotective role. We examined whether LC integrity relates to whole-brain integrity and how AD biomarkers may moderate this relationship.